Navigation Links
Scripps research scientists reveal key structure from ebola virus
Date:7/9/2008

Described in the July 10, 2008 issue of the journal Nature, the research reveals the shape of the Ebola virus spike protein, which is necessary for viral entry into human cells, bound to an immune system antibody acting to neutralize the virus. The structure provides a major step forward in understanding how the deadly virus works, and may be useful in the development of potential Ebola virus vaccines, or treatments for those infected.

"Much about Ebola virus is still a mystery," says Erica Ollmann Saphire, the Scripps Research scientist who led the five-year effort. "However, this structure now reveals how this critical piece of the virus is assembled and, importantly, identifies vulnerable sites that we can exploit."

There is currently no cure for Ebola hemorrhagic fever. The virus is spread when people come into contact with the bodily fluids of someone who is already infected. Most ultimately die from a combination of dehydration, massive bleeding, and shock. The best treatment consists of administering fluids and taking protective measures to ensure containment, like isolating the patient and washing sheets with bleach.

The breakthrough described in the Nature article, though, provides hope that one day modern medicine will have more to offer.

The structure of the antibody together with the viral glycoprotein helps reveal the mechanisms by which the molecules assemble on the viral surface and helps explain how the pathogen evades and exploits the human immune system. The structure also provides a guide for the design of drugs and vaccines to block this protein, potentially preventing disease and death.

The new research was made possible by an antibody isolated by Dennis Burton, a Scripps Research professor and one of the study's coauthors. The antibodyshown bound to the Ebola virus spike protein in the current researchwas derived from bone marrow of one of the few survivors of the 1995 Ebola outbreak in Kikwit, a city in the southwestern part of the Democratic Republic of Congo. The Kikwit outbreak was particularly deadly, with a higher than 90 percent mortality rate for those infected.

In addition to its importance for Ebola, the new research has broader implications for the study of viruses in general.

"Structures of the native, oligomeric forms of viral glycoproteins as they exist on the viral surface are exceedingly difficult to achieve and thus exceedingly rare," notes Ollmann Saphire. "This structure now provides templates by which researchers studying other viruses could try to understand how their virus's surface protein is assembled and neutralized by an antibody."


'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps Research Institute awarded patent for remarkable chemical technology
2. Scripps Oceanography Research pegs ID of red tide killer
3. Fishing throws targeted species off balance, Scripps study shows
4. Bright lights: Mystery of glowing antibody solved by Scripps research scientists
5. Scripps expedition provides new baseline for coral reef conservation
6. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
7. Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
8. Scripps research team blocks bacterial communication system to prevent deadly staph infections
9. Scripps scientists discover fluorescence in key marine creature
10. Significant impact factor boost for scientific journal Genome Research
11. Iowa State researchers study ground cover to reduce impact of biomass harvest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, ... drugs, biologics, cell and gene therapies, and consumer health products, today announced that ... be presenting at the ISCT 2020 Paris Virtual conference, which takes place on ...
(Date:5/14/2020)... ... May 13, 2020 , ... DuPont Nutrition & ... for the lactose-free dairy market. This unique product allows for process optimization and ... at competitive costs across North America. , Among the numerous benefits Bonlacta™ offers, ...
(Date:5/1/2020)... LAUDERDALE, Fla. (PRWEB) , ... April 30, 2020 ... ... accredited telemedicine company backed by Siemens Healthineers and several healthcare VC firms announces ... COVID-19, the goal of CareDoctors.com is to enhance patient care experience by offering ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , ... reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months ... launched as an ecommerce product, where a mom could order her kit online, collect ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic ... ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within the ... continual antimicrobial activity against microorganisms for up to 90 days. , In addition ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... (MBS) has developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and ... with smaller reaction volumes, increased samples per run, and standard, affordable laboratory ...
(Date:4/1/2020)... ... 31, 2020 , ... Bedoukian Research, Inc. (BRI) ... Development Agreement that builds on each company’s expertise in developing efficient routes to ... supply of high-quality insect pheromones as well as flavors and fragrances. P2 has ...
Breaking Biology Technology: